title: Severe contact dermatitis due to ethylenediamine dihydrochloride in nystatin cream.
authors.affiliation: Division of Allergy and Immunology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY. Electronic address: miammatt@montefiore.org.
authors.forename: Melissa
authors.initials: M
authors.lastname: Iammatteo
authors.affiliation: Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY.
authors.forename: Ayobami
authors.initials: A
authors.lastname: Akenroye
authors.affiliation: Division of Allergy and Immunology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY.
authors.forename: Sunit
authors.initials: S
authors.lastname: Jariwala
authors.affiliation: Division of Dermatology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY.
authors.forename: Bonnie
authors.initials: B
authors.lastname: Lee
authors.affiliation: Division of Dermatology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY.
authors.forename: David
authors.initials: D
authors.lastname: Schairer
authors.affiliation: Division of Allergy and Immunology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY.
authors.forename: David
authors.initials: D
authors.lastname: Rosenstreich
mesh_terms: D000279:Administration, Cutaneous; D000328:Adult; D000935:Antifungal Agents / Q000008:administration & dosage*; D003877:Dermatitis, Contact / Q000175:diagnosis / Q000209:etiology*; D004339:Drug Compounding; D045703:Emulsifying Agents / Q000008:administration & dosage / Q000009:adverse effects*; D005029:Ethylenediamines / Q000008:administration & dosage / Q000009:adverse effects*; D005079:Excipients / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009761:Nystatin / Q000008:administration & dosage*; D011310:Preservatives, Pharmaceutical / Q000008:administration & dosage / Q000009:adverse effects*; D012307:Risk Factors; D012720:Severity of Illness Index; D063465:Skin Cream
chemical_list: D000935:Antifungal Agents; D045703:Emulsifying Agents; D005029:Ethylenediamines; D005079:Excipients; D011310:Preservatives, Pharmaceutical; D009761:Nystatin; C031234:ethylenediamine